Pharmaceuticals stocks in India
Every listed pharmaceuticals company on NSE and BSE in our database, largest first, with its valuation, profitability, latest quarterly growth, one-year return and next results date.
There are 228 listed companies in the Pharmaceuticals industry on NSE and BSE in our database, 132 of them with full financials.
The largest by market capitalisation are Sun Pharmaceutical Industries Limited (₹449,036 Cr), Divi's Laboratories Limited (₹293,316 Cr), Torrent Pharmaceuticals Limited (₹175,376 Cr).
Among the 102 companies worth more than ₹500 Cr, the median P/E of the profitable ones is 32.7 and the median return on equity is 13.2%.
Fastest sales growth in the latest quarter (year on year, above ₹500 Cr): Sun Pharma +282%, Strides Pharma +167%, Valiant Laboratories +153%.
Next to report results: Mono Pharmacare on 21 Nov.
Pharmaceuticals companies by market cap
| # | Company | Market cap | P/E | ROE | Qtr sales YoY | Qtr profit YoY | Return 1Y | Next results |
|---|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA | ₹449,036 Cr | 40.92 | 12.3% | +11.9% | -36.2% | +8.1% | — |
| 2 | Divi's Laboratories LimitedDIVISLAB | ₹293,316 Cr | 87.22 | 18.7% | +35.4% | +63.6% | +69.5% | — |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM | ₹175,376 Cr | 83.55 | 25.0% | +50.8% | -9.6% | +20.5% | — |
| 4 | Laurus Labs LimitedLAURUSLABS | ₹125,488 Cr | 94.21 | 22.0% | +33.4% | +124.3% | +134.8% | — |
| 5 | Zydus Lifesciences LimitedZYDUSLIFE | ₹119,900 Cr | 28.35 | 15.2% | +29.2% | -25.3% | +26.3% | — |
| 6 | Dr. Reddy's Laboratories LimitedDRREDDY | ₹116,468 Cr | 42.21 | 7.3% | -1.2% | -36.0% | +13.7% | — |
| 7 | Cipla LimitedCIPLA | ₹114,475 Cr | 40.11 | 8.1% | -2.4% | -37.1% | -6.7% | — |
| 8 | Mankind Pharma LimitedMANKIND | ₹108,424 Cr | 47.91 | 12.9% | +17.3% | +37.7% | +15.6% | — |
| 9 | Aurobindo Pharma LimitedAUROPHARMA | ₹103,355 Cr | 25.93 | 10.1% | +23.9% | +32.5% | +51.8% | — |
| 10 | Lupin LimitedLUPIN | ₹90,173 Cr | 17.27 | 21.7% | +11.1% | -22.2% | -3.0% | — |
| 11 | Glenmark Pharmaceuticals LimitedGLENMARK | ₹74,679 Cr | 51.47 | 12.9% | -29.8% | -56.8% | +43.2% | — |
| 12 | Alkem Laboratories LimitedALKEM | ₹62,443 Cr | 30.09 | 14.0% | +13.8% | -14.4% | -9.4% | — |
| 13 | Biocon LimitedBIOCON | ₹59,279 Cr | 173.99 | 1.0% | +2.2% | -57.3% | -10.8% | — |
| 14 | Abbott IndiaABBOTINDIA | ₹54,122 Cr | 32.73 | 34.6% | +11.0% | +9.2% | -13.9% | — |
| 15 | Gland Pharma LimitedGLAND | ₹53,307 Cr | 43.12 | 11.6% | +23.3% | +58.3% | +75.8% | — |
| 16 | IPCA Laboratories LimitedIPCALAB | ₹47,039 Cr | 31.99 | 16.9% | +13.8% | +32.3% | +38.3% | — |
| 17 | GlaxoSmithKline Pharmaceuticals LimitedGLAXO | ₹44,693 Cr | 38.98 | 61.0% | +20.8% | +30.7% | +5.2% | — |
| 18 | Emcure Pharmaceuticals LimitedEMCURE | ₹44,294 Cr | 40.53 | 20.5% | +24.2% | +29.5% | +70.5% | — |
| 19 | Ajanta Pharma LimitedAJANTPHARM | ₹40,909 Cr | 32.39 | 27.9% | +32.5% | +49.2% | +27.5% | — |
| 20 | Sai Life Sciences LimitedSAILIFE | ₹37,992 Cr | 101.79 | 13.9% | +25.0% | +18.5% | +100.8% | — |
| 21 | Wockhardt LimitedWOCKPHARMA | ₹32,935 Cr | 88.53 | 7.2% | +23.9% | +35.2% | +49.0% | — |
| 22 | Acutaas Chemicals LimitedACUTAAS | ₹32,677 Cr | 74.58 | 23.6% | +42.7% | +71.4% | +133.9% | — |
| 23 | Piramal Pharma LimitedPPLPHARMA | ₹31,687 Cr | 568.68 | 0.7% | +28.0% | -97.4% | +22.1% | — |
| 24 | Neuland Laboratories LimitedNEULANDLAB | ₹27,527 Cr | 60.72 | 22.3% | -12.6% | -46.7% | +22.1% | — |
| 25 | Rubicon Research LimitedRUBICON | ₹27,451 Cr | 84.46 | 22.9% | +39.9% | +67.9% | +164.4% | — |
| 26 | Granules India LimitedGRANULES | ₹21,754 Cr | 30.48 | 10.9% | +20.3% | +39.2% | +47.0% | — |
| 27 | Alembic Pharmaceuticals LimitedAPLLTD | ₹20,528 Cr | 24.41 | 14.1% | +36.3% | +80.8% | +13.9% | — |
| 28 | Eris Lifesciences LimitedERIS | ₹18,551 Cr | 25.83 | 17.3% | +12.6% | +39.2% | -15.1% | — |
| 29 | Onesource Specialty Pharma LimitedONESOURCE | ₹18,190 Cr | — | -0.0% | +37.3% | +474.8% | -9.8% | — |
| 30 | Shilpa Medicare LimitedSHILPAMED | ₹17,902 Cr | 53.82 | 12.8% | +43.0% | +80.0% | +128.9% | — |
| 31 | Alivus Life Sciences LimitedALIVUS | ₹17,737 Cr | 26.48 | 18.4% | +16.0% | +51.3% | +58.9% | — |
| 32 | Pfizer LimitedPFIZER | ₹17,575 Cr | 20.45 | 19.6% | +13.2% | +65.7% | -23.4% | — |
| 33 | Cohance Lifesciences LimitedCOHANCE | ₹17,462 Cr | — | -0.2% | -14.2% | -96.6% | -33.8% | — |
| 34 | Caplin Point Laboratories LimitedCAPLIPOINT | ₹15,851 Cr | 22.63 | 18.3% | +17.9% | +13.8% | +7.2% | — |
| 35 | AstraZeneca Pharma India LimitedASTRAZEN | ₹15,109 Cr | 84.95 | 20.2% | +30.4% | +15.4% | -34.9% | — |
| 36 | Natco Pharma LimitedNATCOPHARM | ₹15,099 Cr | 19.23 | 8.0% | -29.0% | -59.6% | -0.2% | — |
| 37 | Jubilant Pharmova LimitedJUBLPHARMA | ₹14,789 Cr | 56.36 | 3.7% | +20.5% | -74.2% | -18.1% | — |
| 38 | CORONA Remedies LimitedCORONA | ₹13,787 Cr | 66.68 | 25.7% | +22.2% | +16.0% | — | — |
| 39 | Sudeep Pharma LimitedSUDEEPPHRM | ₹13,579 Cr | 71.69 | 19.8% | +20.9% | +10.8% | — | — |
| 40 | Marksans Pharma LimitedMARKSANS | ₹13,346 Cr | 23.58 | 17.0% | +30.6% | +45.0% | +49.5% | — |
| 41 | Akums Drugs and Pharmaceuticals LimitedAKUMS | ₹10,964 Cr | 30.08 | 10.4% | +31.9% | +168.3% | +63.3% | — |
| 42 | Viyash Scientific LimitedVIYASH | ₹10,399 Cr | 37.34 | 8.8% | +2803.1% | +2648.4% | — | — |
| 43 | Symbiotec Pharmalab LimitedSYMBIOTEC | ₹10,252 Cr | — | — | — | — | — | — |
| 44 | Aarti Pharmalabs LimitedAARTIPHARM | ₹9,189 Cr | 35.81 | 11.4% | +45.9% | +156.0% | +33.4% | — |
| 45 | Procter & Gamble Health LimitedPGHL | ₹9,138 Cr | 24.01 | 57.8% | +17.7% | +25.3% | -6.6% | — |
| 46 | Blue Jet Healthcare LimitedBLUEJET | ₹8,993 Cr | — | — | -17.4% | -14.2% | -10.8% | — |
| 47 | Strides Pharma Science LimitedSTAR | ₹8,831 Cr | 16.04 | 16.1% | +166.6% | +318.6% | +3.7% | — |
| 48 | Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹8,147 Cr | 29.16 | — | +12.4% | +21.6% | -24.2% | — |
| 49 | Sanofi India LimitedSANOFI | ₹7,443 Cr | 20.38 | — | +3.5% | +53.6% | -29.7% | — |
| 50 | Bliss GVS Pharma LimitedBLISSGVS | ₹7,238 Cr | 43.47 | 14.0% | +28.4% | +83.9% | +323.5% | — |
| 51 | Sun Pharma Advanced Research Company LimitedSPARC | ₹6,170 Cr | 3.77 | 113.4% | +282.1% | +67.8% | +43.0% | — |
| 52 | FDC LimitedFDC | ₹6,087 Cr | 19.48 | 11.7% | +21.0% | +75.2% | -8.2% | — |
| 53 | Innova Captab LimitedINNOVACAP | ₹6,009 Cr | 11.79 | 43.6% | +30.6% | +41.4% | +48.3% | — |
| 54 | Concord Biotech LimitedCONCORDBIO | ₹5,869 Cr | 21.02 | 13.5% | +25.1% | +10.3% | -23.3% | — |
| 55 | IOL Chemicals and Pharmaceuticals LimitedIOLCP | ₹5,569 Cr | 27.43 | 10.5% | +40.1% | +117.1% | +92.6% | — |
| 56 | Morepen Laboratories LimitedMOREPENLAB | ₹5,061 Cr | 26.75 | 13.7% | +81.4% | +116.6% | +96.2% | — |
| 57 | Senores Pharmaceuticals LimitedSENORES | ₹5,032 Cr | 36.56 | 13.7% | +18.9% | +21.5% | +40.7% | — |
| 58 | Supriya Lifescience LimitedSUPRIYA | ₹4,948 Cr | 27.96 | 14.2% | +3.2% | -42.0% | -19.4% | — |
| 59 | Orchid Pharma LimitedORCHPHARMA | ₹4,848 Cr | 111.02 | 2.7% | +76.3% | +957.4% | +17.9% | — |
| 60 | Gujarat Themis Biosyn LimitedGUJTHEM | ₹4,722 Cr | — | — | — | — | -19.4% | — |
P/E "n/m" means the company made a loss over the last four quarters. Quarterly growth compares the latest quarter with the same quarter a year earlier. "—" means the figure is not available.
More pharmaceuticals companies
Upcoming pharmaceuticals results
Frequently asked questions
Which are the largest pharmaceuticals stocks in India?
By market capitalisation: Sun Pharmaceutical Industries Limited (₹449,036 Cr), Divi's Laboratories Limited (₹293,316 Cr), Torrent Pharmaceuticals Limited (₹175,376 Cr), Laurus Labs Limited (₹125,488 Cr), Zydus Lifesciences Limited (₹119,900 Cr).
How many pharmaceuticals companies are listed in India?
228 companies listed on NSE and BSE are classified in the Pharmaceuticals industry on this page, which merges the different labels used for the same business.
What is the average P/E of pharmaceuticals stocks?
The median P/E of profitable pharmaceuticals companies worth more than ₹500 Cr is 32.7, based on trailing-twelve-month profit and the latest close.
When do pharmaceuticals companies announce their results?
Upcoming board meetings for results: Mono Pharmacare Limited on 21 Nov 2026.